What’s new

• Battery materials project cost revised to ₹1,795 crore, a 20% jump from the ₹1,500 crore estimate.
• Dahej Phase 1 project completion pushed to February 2027.
• Standalone revenue guidance for FY27 is ₹875-950 crore.

Why it matters

A 20% cost overrun on a project that hasn't produced revenue yet changes the return-on-capital calculus. The delay to February 2027 pushes cash-flow breakeven further out, while the ₹161 cr promoter infusion and expected $20M from Morita only cap debt growth—they don't reduce the total investment.

What we’re watching

• Whether the ₹1,795 cr cost is now final or subject to more revisions.
• Customer qualification progress at the Pakhajan greenfield site.
• Timing of the remaining $20M equity infusion from Morita.

The full read

Neogen Chemicals' battery materials bet just got more expensive. The project cost at subsidiary Neogen Ionics has been revised to ₹1,795 crore, a 20% jump from the earlier ₹1,500 crore estimate. The increase comes from integrating Japanese technology and adding intermediate capacity. Compounding the capital pressure, the Dahej Phase 1 project completion has been pushed to February 2027. The standalone business, which excludes battery materials, is guiding revenue of ₹875-950 crore for FY27, with the Dahej replacement plant due in June 2026. The ₹161 crore promoter infusion and an expected $20 million equity contribution from partner Morita are meant to cap peak debt. But a 20% cost escalation on a project yet to generate revenue changes the return math. The standalone revenue anchor is stable. The battery story is now both more costly and slower to deliver.

Primary source: BSE · NSE